University of Cambridge > > euroscicon > Stem cells: from basic research to bioprocessing

Stem cells: from basic research to bioprocessing

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Speaker to be confirmed.

Three Day Event

This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming (including new insights into the molecular basis of pluripotency and differentiation) together with the progress towards therapeutic and bioprocessing.

This event has CPD accreditation

This event has an open abstract session. Abstracts can be submitted on any subject related to Stem Cells The Deadline for abstract submissions for oral presentation is March 10th 2015 Abstracts for poster presentation only can be submitted up to two weeks before the event .You can download the instructions for authors at

Who Should Attend Anyone with an interest in stem cell biology, differentiation and use in biomedicine should attend this event, including, but not exclusively people from: Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students

Talks include

MicroRNA Activity and Adult Stem Cell Differentiation: Utilising the Epigenome Assistant Professor Christopher J. Payne, PhD, Human Molecular Genetics Program, Ann & Robert H. Lurie Children’s Hospital of Chicago Research Center, Departments of Pediatrics and Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States TBC Dr. PV. Mohanan, PhD, FST , FASc(Aw), FSAB , Scientist & Head, Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Poojapura, Thiruvananthapuram, Kerala, India

Direct Conversion of Pluripotent Human Embryonic Stem Cells into Functional Human Neuronal or Cardiomyocyte Cell Therapy Derivatives for Regenerative Medicine Dr. Xuejun H Parsons, San Diego Regenerative Medicine Institute & Xcelthera Inc, San Diego, CA, United States

Synthetic mRNAs as optimised tools for stem cell generation and for manipulating cellular phenotypes Dr. Guido Krupp, CEO and President, AmpTec GmbH, Koenigstr. 4A D-22767 Hamburg, Germany

Decellularized organs: Whole organ construction with stem cells Dr Karthikeyan Narayanan, Senior Research Scientist, Institute of Bioengineering and Nanotechnology, NANOS , Biopolis, Singapore

The identification of novel factors involved in migration of stem cells to site of injury Dr Adiba Isa, Postdoc, Dr.Med.Sci., Laboratory of Molecular Endocrinology (KMEB), Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark

TBC Dr Gabor FoldesGabor Foldes, MD PhD, National Heart and Lung Institute, Imperial College London, Imperial Centre for Experimental and Translational Medicine, Hammersmith Campus, London, UK

TBC Dr Patrizia Ferretti, Stem Cells and Regenerative Medicine Section, UCL Institute of Child Health, London, UK

TBC Dr Marianne Ellis, RAEng/The Leverhulme Trust Senior Research Fellow, Senior Lecturer, Department of Chemical Engineering, University of Bath, Bath, UK

This talk is part of the euroscicon series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity